Kirvis Torres-Poveda
Overview
Explore the profile of Kirvis Torres-Poveda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
462
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torres-Poveda K, Bahena-Roman M, Contreras-Ochoa C, Lagunas-Martinez A, Bermudez-Morales V, Pando-Robles V, et al.
BMC Infect Dis
. 2025 Mar;
25(1):315.
PMID: 40045221
Background: COVID-19 was the leading cause of death in Mexico between 2020 and 2021. SARS-CoV-2 infection varies widely among individuals and populations. Since variations in genes related to the immune...
2.
Aguilar-Linares G, Marquez-Serrano M, Meneses-Navarro S, Pelcastre-Villafuerte B, Castillo-Castillo L, Estevez-Garcia J, et al.
BMC Womens Health
. 2024 Oct;
24(1):550.
PMID: 39367365
Background: Mexico reports low follow-up completion rates among women with abnormal cervical cancer screenings. This study aimed to identify barriers and facilitators to follow-up adherence among women with human papillomavirus...
3.
Luvian-Morales J, Gutierrez-Enriquez S, Granados-Garcia V, Torres-Poveda K
Front Oncol
. 2024 Jun;
14:1378549.
PMID: 38846977
Introduction: Cervical cancer (CC) is the fourth most prevalent female cancer globally. Understanding its epidemiology is crucial for devising practical strategies suited to geographic and social contexts to attain the...
4.
Saldana-Rodriguez P, Bahena-Roman M, Delgado-Romero K, Madrid-Marina V, Torres-Poveda K
Cancer Control
. 2023 Sep;
30:10732748231202925.
PMID: 37751562
Background: A persistent infection by high-risk human papillomavirus (HR-HPV) is a prerequisite for the development of cervical neoplasms; however, most studies have focused on risk factors associated with HPV-16 and...
5.
Cruz-Valdez A, Palacio-Mejia L, Quezada-Sanchez A, Hernandez-Avila J, Galicia-Carmona T, Cetina-Perez L, et al.
Front Oncol
. 2023 Mar;
13:1008560.
PMID: 36969022
Introduction: The COVID-19 pandemic disrupted the preventive services for cervical cancer (CC) control programs in Mexico, which will result in increased mortality. This study aims to assess the impact of...
6.
Ramirez-Gonzalez A, Avila-Lopez P, Bahena-Roman M, Contreras-Ochoa C, Lagunas-Martinez A, Langley E, et al.
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36835622
The human gene encodes an AT-hook transcription factor, the expression of which is involved in various cellular processes. The goal of this study was to identify potential AKNA binding sites...
7.
Rojas-Garcia M, Vazquez B, Torres-Poveda K, Madrid-Marina V
BMC Infect Dis
. 2023 Jan;
23(1):18.
PMID: 36631853
Background: Mexico ranks fifth worldwide in the number of deaths due to COVID-19. Identifying risk markers through easily accessible clinical data could help in the initial triage of COVID-19 patients...
8.
Olmedo-Nieva L, Munoz-Bello J, Martinez-Ramirez I, Martinez-Gutierrez A, Ortiz-Pedraza Y, Gonzalez-Espinosa C, et al.
Cells
. 2022 Dec;
11(23).
PMID: 36497200
High-risk human papillomavirus (HPV) infection is the main risk factor for cervical cancer (CC) development, where the continuous expression of E6 and E7 oncoproteins maintain the malignant phenotype. In Mexico,...
9.
Contreras-Ochoa C, Bahena-Roman M, Lopez-Diaz L, Lagunas-Martinez A, Mojica-Cardoso C, Manzo-Merino J, et al.
Iran J Basic Med Sci
. 2022 Jun;
25(3):383-389.
PMID: 35656191
Objectives: Infection with high-risk human papillomavirus is required to develop cervical cancer. Some viruses modulate the Fas/FasL signaling to evade the immune response; the role of these molecules in cervical...
10.
Vega-Villalobos A, Almanza-Ortega N, Torres-Poveda K, Perez-Ortega J, Barahona I
PLoS One
. 2022 Mar;
17(3):e0264713.
PMID: 35298483
In most big cities, public transports are enclosed and crowded spaces. Therefore, they are considered as one of the most important triggers of COVID-19 spread. Most of the existing research...